VRTX monthly performance report
View VRTX's monthly returns, drawdown, and seasonality trends — updated every month.
VRTX monthly report
—
Key takeaways
- Vertex Pharmaceuticals (VRTX) closed September 2026 at $508.34, down 6.64% for the month and +31.32% over the trailing 12 months.
- Year-to-date, VRTX is +12.13%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +8.42% versus its 200-day moving average ($468.87), a bullish technical signal.
- Over the past three years, VRTX has underperformed the S&P 500 by −27.28%, with a relative strength index reading of 84.1.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Vertex Pharmaceuticals ended September 2026 at $508.34, posting a monthly return of −6.64%. The S&P 500 returned −0.70% over the same window, leaving relative performance at −5.95%.
The current quarter stands at +2.34% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +8.42% versus the 200-day moving average ($468.87).
Year-to-date, VRTX is +12.13% against SPY +11.70%, a gap of +0.43%. The stock is currently −8.95% below its 52-week high, with maximum 3-year drawdown at −29.07%.
| Period | VRTX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −1.55% | −0.12% | −1.43% |
| 1 Week | −1.38% | −0.34% | −1.04% |
| 1 Month | −6.64% | −0.70% | −5.95% |
| 3 Months | +12.17% | +2.80% | +9.38% |
| 6 Months | +8.31% | +13.85% | −5.54% |
| YTD | +12.13% | +11.70% | +0.43% |
| 12 Months | +31.32% | +15.01% | +16.30% |
| 3 Years | +44.41% | +71.69% | −27.28% |
| Rank | Month | Return |
|---|---|---|
| #1 | May 2024 | +15.92% |
| #2 | Dec 2023 | +14.68% |
| #3 | Jan 2025 | +14.65% |
| #4 | Aug 2026 | +14.13% |
| #5 | Jun 2026 | +10.99% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2025 | −14.41% |
| #2 | Dec 2024 | −13.98% |
| #3 | May 2025 | −13.24% |
| #4 | Mar 2026 | −10.12% |
| #5 | Sep 2026 | −6.64% |
| Quarter | Return |
|---|---|
| Q2 2025 | −8.17% |
| Q3 2025 | −12.03% |
| Q4 2025 | +15.76% |
| Q1 2026 | −1.50% |
| Q2 2026 | +11.24% |
| Q3 2026 (QTD) | +2.34% |
| Year | Return |
|---|---|
| 2023 | +40.90% |
| 2024 | −1.03% |
| 2025 | +12.58% |
| 2026 | +12.13% |
| Metric | Value |
|---|---|
| 52-Week High | $558.33 (2026-09-02) |
| 52-Week Low | $374.17 (2025-09-24) |
| Current Price | $508.34 |
| 200-Day Moving Average | $468.87 |
| Price vs 200DMA | +8.42% |
| 3-Year Maximum Drawdown | −29.07% (2025-08-08) |
| Current Drawdown from 52W High | −8.95% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 84.1 |
| 3-Year Excess Return vs S&P 500 | −27.28% |
| RS Peak | 119.9 (Apr 2025) |
| RS Trough | 70.5 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was VRTX's return for this report period?
VRTX returned −6.64% in the latest monthly window ending 2026-09-18.
Has VRTX outperformed SPY year to date?
YTD VRTX: +12.13% vs SPY: +11.70%.
What is VRTX's 12-month return?
+31.32% over the trailing 12 months.
Is VRTX above or below its 200-day moving average?
Price is +8.42% versus 200DMA ($468.87).
What is the maximum drawdown in the 3-year window?
−29.07% on 2025-08-08.